KIA
RMD icon

Knollwood Investment Advisory’s ResMed RMD Stock Holding History

Knollwood Investment Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,450
Closed -$1.45M – 307
2026
Q1 		$1.45M Hold
6,450
– – 0.15% 130
2025
Q4 		$1.55M Hold
6,450
– – 0.15% 139
2025
Q3 		$1.77M Hold
6,450
– – 0.16% 130
2025
Q2 		$1.66M Hold
6,450
– – 0.16% 140
2025
Q1 		$1.44M Hold
6,450
– – 0.16% 147
2024
Q4 		$1.48M Hold
6,450
– – 0.15% 149
2024
Q3 		$1.57M Hold
6,450
– – 0.17% 145
2024
Q2 		$1.23M Buy
+6,450
New +$1.31M 0.14% 164

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Knollwood Investment Advisory's RMD Position: Q2 2026 in Review

Knollwood Investment Advisory sold out of ResMed (RMD) in Q2 2026, closing a stake of 6,450 shares — an estimated $1.45M sold.

Knollwood Investment Advisory first reported a position in RMD in Q2 2024 and held it in 8 quarters. The position peaked at $1.77M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Knollwood Investment Advisory reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Knollwood Investment Advisory sold 6,450 ResMed shares in Q2 2026, an estimated $1.45M.
  • Knollwood Investment Advisory first reported a position in ResMed in Q2 2024 and held it in 8 quarters.
  • Knollwood Investment Advisory's ResMed position peaked at $1.77M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.